Headline
The latest stories from AHA Today.
AHA Feb. 5 voiced support for many provisions in a proposed rule to improve how the No Surprises Act independent dispute resolution process functions, but said the departments of Health and Human Services, Labor and the Treasury still need to address several issues critical to the functionality of…
Northern Light Health in Brewer, Maine, partnered with Morehouse School of Medicine to create a rural residency program for physician assistants.
A bipartisan group of senators Feb. 2 released for stakeholder feedback a discussion draft of legislation to clarify in statute Congress’ intent for the 340B program to help safety net providers maintain, improve and expand patient access to health care services by requiring drug manufacturers that…
The AHA, joined by five other national associations representing hospitals, Feb. 2 urged the U.S. Supreme Court to review a case challenging how the Department of Health and Human Services applies Congress’ formula for calculating Disproportionate Share Hospital payments.
The Substance Abuse and Mental Health Services Administration Jan. 31 updated its Overdose Prevention and Response Toolkit.
AHA Feb. 1 released its 2024 advocacy agenda, which details the association’s key priorities for Congress, the Administration, regulatory agencies and courts.
The Centers for Medicare & Medicaid Services will accept comments through March 1 at 6 p.m. ET on its advance notice of proposed changes to Medicare Advantage plan capitation rates and Part C and Part D payment policies for calendar year 2025, which the agency estimates will increase MA plan…
The Substance Abuse and Mental Health Services Administration has issued a final rule updating regulations for Opioid Treatment Programs and standards for opioid use disorder treatment.
The Cybersecurity & Infrastructure Security Agency and FBI Jan. 31 urged small office and home office router manufacturers to eliminate exploitable defects in their products and integrate security into their product design and development, citing recent reports that threat actors known as “Volt…
The Cell and Gene Therapy Access Model, which seeks to increase access to treatments for Medicaid enrollees with rare and severe diseases, will initially focus on sickle cell disease, the Centers for Medicare & Medicaid Services announced.